Nuclear Medicine: Page 74

SNMMI warns of Mo-99 shortage in early November

By AuntMinnie.com staff writers

The double whammy of simultaneous nuclear reactor shutdowns in South Africa and Australia is expected to cause a significant shortage of molybdenum-99 (Mo-99) in the first half of November, according to an alert issued by the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

October 31, 2018

Suit against Navidea dismissed

By AuntMinnie.com staff writers

A lawsuit filed against radiopharmaceutical developer Navidea Biopharmaceuticals by Platinum-Montaur Life Sciences has been dismissed.

October 31, 2018

Lantheus revenues, earnings rise in Q3

By AuntMinnie.com staff writers

Double-digit sales growth in its Definity and TechneLite contrast agent product lines boosted Lantheus Medical Imaging parent company Lantheus Holdings to an 11.2% increase in worldwide revenues in its third quarter.

October 30, 2018

Navidea receives acceptance letter from NYSE American

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals said the New York Stock Exchange (NYSE) American has accepted the company's plan to regain compliance with stock listing standards.

October 30, 2018

So, how is that PET/MRI working out for you?

By Wayne Forrest

Thursday, November 29 | 11:20 a.m.-11:30 a.m. | SSQ14-06 | Room S505ABIn this presentation, German researchers will look back at the clinical evolution of PET/MRI and how image acquisition times, protocol complexity, and tracer dosage have changed.

October 30, 2018

PET/MRI works for cancer staging in pediatric patients

By Wayne Forrest

Wednesday, November 28 | 12:45 p.m.-1:15 p.m. | PD191-ED-WEB7 | Lakeside, PD Community, Station 7PET/MRI has shown diagnostic value for cancer staging in adult patients, but what value does the hybrid modality provide for pediatric patients? Researchers from Stanford University answer this question in an educational exhibit.

October 30, 2018

Shine takes delivery of 1st production accelerator

By AuntMinnie.com staff writers

Medical isotope firm Shine Medical Technologies on October 15 took delivery of the first production accelerator at its new medical isotope production campus in Janesville, WI.

October 17, 2018

Novartis to buy Endocyte for $2.1B

By AuntMinnie.com staff writers

Novartis announced that it plans to buy therapeutic radiopharmaceutical developer Endocyte for $2.1 billion.

October 17, 2018

RefleXion to show PET-guided RT at ASTRO

By AuntMinnie.com staff writers

Radiation therapy equipment developer RefleXion Medical plans to highlight a new PET-guided approach to radiotherapy (RT) at the upcoming American Society for Radiation Oncology (ASTRO) meeting in San Antonio.

October 17, 2018

Quantitative PET better estimates amyloid plaque burden

By Wayne Forrest

Dutch researchers have developed a quantitative method of analyzing PET images acquired with the radiopharmaceutical flutemetamol that may top semiquantitative methods for identifying dementia-causing amyloid plaque, according to a study published online October 12 in the Journal of Nuclear Medicine.

October 17, 2018

Cardinal Health taps new head of pharmaceutical unit

By AuntMinnie.com staff writers

Radiopharmaceutical supplier Cardinal Health has hired Victor Crawford to be the CEO of its pharmaceutical segment, effective November 12.

October 15, 2018

Vivos raises money to advance products, nix debt

By AuntMinnie.com staff writers

Medical isotope developer Vivos late last month completed a common stock equity financing that raised money to eliminate debt and advance product development.

October 9, 2018

Previous Page

Page 74 of 445

Next Page